FYMILSI Trademark
FYMILSI is a USPTO trademark filed by Bristol-Myers Squibb Company. Status: Pending.
Trademark Facts
| Mark | FYMILSI |
|---|---|
| Serial Number | 99030058 |
| Status | Pending |
| Filing Date | 2025-02-05 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Bristol-Myers Squibb Company |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 9 |
| Latest Event | NOAM on 2025-10-21 |
Goods & Services
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; stem cells for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes; radiopharmaceutical preparations for the treatment of cancer and immune system related diseases and disorders